期刊文献+

粉末包衣技术制备替比培南酯细粒剂 被引量:6

下载PDF
导出
摘要 目的:制备替比培南酯细粒剂。方法:采用流化床粉末包衣技术,以乙基纤维素混悬液、丙烯酸乙酯-甲基丙烯酸甲酯共聚物(2∶1)水分散体、羟丙甲纤维素E5和滑石粉为包衣材料,采用正交试验法考查了不同配比的包衣材料对替比培南酯细粒剂的体外溶出行为的影响。结果:优化后的包衣处方为乙基纤维素混悬液∶丙烯酸乙酯-甲基丙烯酸甲酯共聚物(2∶1)水分散体∶羟丙甲纤维素E5∶滑石粉=100∶100∶30∶100。结论:成功制备了替比培南酯细粒剂,其体外溶出行为和原研品基本一致。
出处 《天津药学》 2016年第2期18-20,共3页 Tianjin Pharmacy
  • 相关文献

参考文献3

二级参考文献61

  • 1Abe T,Hayashi K,Mihira A,et al.L-084,a new oral carbapenem:Synthesis and structure-activity relationships of C2substituted 1beta-methylcarbapenems.38th Intersci Conf Antimicrob Agents Chemother (ICAAC),(Sept 24-27,San Diego),1998,Abst F-64.
  • 2Isoda T,Sato C,Mihira A,et al.(Wyeth-Lederle Japan,Ltd.).2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thiocarbapenem derivatives.EP 0632039,EP 0717042,JP 1996053453,US 5534510,US 5659043,US 5783703.
  • 3Kumagai T.(Wyeth-Lederle Japan,Ltd.).Carbapenem-3-carboxylic acid ester derivatives.EP 0808315,JP 1999504039,US 5886172,WO 9721712.
  • 4Yasuda S,Okue M,Hori N.(Meiji Seika Kaisha,Ltd).Process for producing carbapenem derivative and intermediate for use in the production.WO 2004035539.
  • 5Nishino K,Koga T.(Kaneka Corporation).Process for producing carbapenem compound for oral administration.EP 1580191.
  • 6西野敬太,古贺照义.经口给药用碳青霉素烯化合物的新的合成中间体及其制造方法.CN1708504A.
  • 7Kato N,Kato H,Tanaka K,Watanabe K.L-084,a new oral carbapenem:In vitro activity against anaerobic bacteria.38th Intersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 24-27,San Diego),1998,Abst F-70.
  • 8Kobayashi R,Konomi N,Hasegawa K,et al.In vitro antivity of tebipenem,a new oral carbapenem antibiotic,against penicillin-nonsusceptible Streptococcus pneumonia.Antimicrob Agents Chemother,2005,49:889-894.
  • 9Hanaki H,Sasaki K,Inaba Y,et al.L-084,a new oral carbapenem:In vitro activity against clinical isolated strains including vancomycin low-restraint Staphylococcus aureus and its binding affinity to PBPs.38th Intersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 24-27,San Diego),1998,Abst F-66.
  • 10Hikida M,Itahashi K,Igarashi A,et al.In Vitro antibacterial activity of LJC 11,036,an active metabolite of L-084,a new oral carbapenem antibiotic with potent antipneumococcal activity.Antimicrob Agents Chemother,1999,43:2010-2016.

共引文献42

同被引文献37

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部